News

The agreement adds to the existing pharmaceutical agents focused on targets in oncology and inflammation being developed by the Hutchison MediPharma group for Lilly. Under the agreement, Hutchison

The company, which has bases in the UK, the US and Romania, said that it will use the new funds from Scottish Equity Partners (SEP) to expand its

The study encompasses both patients with very high triglycerides and mixed dyslipidemia and includes normal weight, overweight and obese patients presenting with or without hypertension. The randomized, double-blind

The agreement outlines the proposed terms for establishing a joint venture (JV) company, which will seek to co-develop seasonal influenza vaccines and pre-pandemic or pandemic influenza vaccines, firstly

In these patients, RoActemra can be given as monotherapy in cases of intolerance to methotrexate (MTX) or where continued treatment with MTX is inappropriate. RoActemra is said to

Filgrastim is indicated for use in treating neutropenia, a condition characterized by lack of neutrophils – one of the most common types of white blood cells – that

The submission was through the centralized procedure and this new formulation allows once-daily dosing: Competact (pioglitazone HCl and metfomin HCl) is currently available in some European countries as

Naproxcinod 750mg bid showed the same gastrointestinal (GI) adverse event rate and a similar blood pressure profile to placebo. Following the positive results from the 301 and 302

Mediware’s purchase agreement includes a cash payment of approximately $3.5 million, with an additional earn out opportunity based on operational performance. According to the company, the addition of